TAFI activity in coronary artery disease: A contribution to the current discussion on TAFI assays

被引:19
作者
Schroeder, Verena
Wilmer, Marianne
Buehler, Beatrice
Kohler, Hans P.
机构
[1] Univ Hosp Bern, Inselspital, Lab Thrombosis Res, Dept Clin Res,Kinderklin G3, CH-3010 Bern, Switzerland
[2] Pentapharm Ltd, CH-4002 Basel, Switzerland
关键词
D O I
10.1160/TH06-06-0295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:236 / 237
页数:2
相关论文
共 7 条
  • [1] Development of a genotype 325-specific proCPU/TAFI ELISA
    Gils, A
    Alessi, MC
    Brouwers, E
    Peeters, M
    Marx, P
    Leurs, J
    Bouma, B
    Hendriks, D
    Juhan-Vague, I
    Declerck, PJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (06) : 1122 - 1127
  • [2] Association between thrombin activatable fibrinolysis inhibitor genotype and levels in plasma: comparison of different assays
    Guimaraes, AHC
    van Tilburg, NH
    Vos, HL
    Bertina, RM
    Rijken, DC
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (05) : 659 - 665
  • [3] Carboxypeptidase U (TAFla): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease
    Leurs, J
    Hendriks, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 2005, 94 (03) : 471 - 487
  • [4] TAFI
    Nesheim, ME
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1999, 13 (02): : 72 - 77
  • [5] Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography
    Schroeder, V
    Chatterjee, T
    Mehta, H
    Windecker, S
    Pham, T
    Devantay, N
    Meier, B
    Kohler, HP
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 88 (06) : 1020 - 1025
  • [6] Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAR levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD)
    Verdú, J
    Marco, P
    Benlloch, S
    Sanchez, J
    Lucas, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 2006, 95 (03) : 585 - 586
  • [7] A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor
    Wang, W
    Boffa, PB
    Bajzar, L
    Walker, JB
    Nesheim, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) : 27176 - 27181